Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA GLENMARK PHARMA AJANTA PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 23.7 13.5 175.1% View Chart
P/BV x 4.9 1.3 363.6% View Chart
Dividend Yield % 0.8 0.6 131.9%  

Financials

 AJANTA PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
GLENMARK PHARMA
Mar-22
AJANTA PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,614691 233.7%   
Low Rs1,089416 261.9%   
Sales per share (Unadj.) Rs391.1436.1 89.7%  
Earnings per share (Unadj.) Rs83.435.2 236.9%  
Cash flow per share (Unadj.) Rs98.152.5 187.0%  
Dividends per share (Unadj.) Rs9.502.50 380.0%  
Avg Dividend yield %0.70.5 155.5%  
Book value per share (Unadj.) Rs382.1321.4 118.9%  
Shares outstanding (eoy) m85.42282.17 30.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.51.3 272.4%   
Avg P/E ratio x16.215.7 103.1%  
P/CF ratio (eoy) x13.810.5 130.7%  
Price / Book Value ratio x3.51.7 205.5%  
Dividend payout %11.47.1 160.4%   
Avg Mkt Cap Rs m115,433156,067 74.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45824,474 26.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410123,049 27.2%  
Other income Rs m1,1571,667 69.4%   
Total revenues Rs m34,567124,716 27.7%   
Gross profit Rs m9,29320,594 45.1%  
Depreciation Rs m1,2534,867 25.7%   
Interest Rs m1022,981 3.4%   
Profit before tax Rs m9,09514,412 63.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9684,476 44.0%   
Profit after tax Rs m7,1279,936 71.7%  
Gross profit margin %27.816.7 166.2%  
Effective tax rate %21.631.1 69.7%   
Net profit margin %21.38.1 264.2%  
BALANCE SHEET DATA
Current assets Rs m24,54882,823 29.6%   
Current liabilities Rs m8,37746,894 17.9%   
Net working cap to sales %48.429.2 165.8%  
Current ratio x2.91.8 165.9%  
Inventory Days Days426 647.8%  
Debtors Days Days1192 12.1%  
Net fixed assets Rs m19,25971,148 27.1%   
Share capital Rs m172282 60.8%   
"Free" reserves Rs m32,46990,421 35.9%   
Net worth Rs m32,64090,703 36.0%   
Long term debt Rs m1625,717 0.1%   
Total assets Rs m43,807153,972 28.5%  
Interest coverage x90.25.8 1,545.3%   
Debt to equity ratio x00.3 0.2%  
Sales to assets ratio x0.80.8 95.4%   
Return on assets %16.58.4 196.7%  
Return on equity %21.811.0 199.3%  
Return on capital %28.214.9 188.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m18,67832,142 58.1%   
Fx outflow Rs m3,66213,482 27.2%   
Net fx Rs m15,01618,660 80.5%   
CASH FLOW
From Operations Rs m5,62011,087 50.7%  
From Investments Rs m-741-3,333 22.2%  
From Financial Activity Rs m-4,600-5,205 88.4%  
Net Cashflow Rs m2792,724 10.2%  

Share Holding

Indian Promoters % 70.5 46.7 151.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.4 34.1 62.7%  
FIIs % 8.2 23.1 35.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 53.4 55.3%  
Shareholders   62,048 313,540 19.8%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on AJANTA PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Glenmark Pharma Share Price Performance

Period AJANTA PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.54% 0.45% -0.43%
1-Month -7.52% 3.36% -2.31%
1-Year -11.88% -14.48% -5.93%
3-Year CAGR 23.53% 9.18% 20.83%
5-Year CAGR 6.92% -4.45% 11.40%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 7.1%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.